High Times Apr 11, 2024

Amended Maine Bill to Establish Psychedelic Research Committee Heads to Gov.

It’s a disappointing turn of events for those pushing for urgent access to psychedelic medicines and treatments, though Maine lawmakers in favor of psychedelic reform still recognized that the bill “represents progress.”

Psychedelic Alpha Apr 9, 2024

MindMed’s ‘Total Elimination’ of Psychotherapy in LSD Study Stokes Debate Around Its Role in Psychedelic Therapies

Psychedelic Alpha‘s Josh Hardman speaks with people close to the study itself as well as MindMed representatives including CEO Robert Barrow to look at the (unpublished) protocol employed in the Phase 2b study.

Marijuana Moment Apr 5, 2024

Missouri House Approves Bill with $10 Million to Research Psilocybin for Opioid Addiction

Money for the program would come from state opioid settlement funds, the result of multiple lawsuits filed against the opioid industry and peripheral businesses.

PsyPost Apr 4, 2024

Ayahuasca Retreats Appear to Lead to a Lasting Boost in Aesthetic Appreciation

Individuals who consumed the psychedelic experienced a significant increase in their appreciation for aesthetic experiences, not just momentarily but extending up to a month post-consumption, according to new research.

Psychedelic Alpha Apr 3, 2024

Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program

Psychedelic Alpha‘s Josh Hardman speaks with the chief sponsor of Utah SB 266, which became law last month.

Marijuana Moment Apr 2, 2024

DEA Agrees To Hold Hearing on Proposed Ban of Two Psychedelics

The agency will convene the meeting on June 10, at the request of three interested parties, including Panacea Plant Sciences, which had filed a motion contesting the proposed scheduling action last year.

Oregon Public Broadcasting Apr 1, 2024

Portland VA Opens Lab to Treat Veterans with Psychedelics

Last week the VA Portland Health Care System opened the Social Neuroscience & Psychotherapy Lab, known as the SNaP Lab, focused on psychedelic therapy and clinical trials.

Marijuana Moment Mar 27, 2024

Mass. Lawmakers Take Up Psychedelics Legalization Ballot Initiative

If lawmakers decide not to legalize psychedelics by May 1, activists would then have until July 3 to submit at least 12,429 additional valid signatures to put the proposal before voters on the November ballot.

Filter Mar 26, 2024

Utah’s New Law Authorizes MDMA and Psilocybin Therapy

On March 21, Utah Governor Spencer Cox (R) announced that while he’s not signing a psychedelic bill, he’s not vetoing it either. He’s letting it take effect without a signature, on May 1.

Double Blind Mar 25, 2024

Study: Psychedelic Use Linked to ‘Lower Rates of Psychotic Symptoms’ in Adolescents

Manic symptoms, meanwhile, were linked to psychedelic use, but that appeared to be due to genetic predisposition.

Marijuana Moment Mar 19, 2024

Maryland Senate Approves Bill To Study ‘Equitable and Affordable’ Access To Psilocybin And DMT

The legislation would establish a “Task Force on Responsible Use of Natural Psychedelic Substances” that would be overseen by the Maryland Cannabis Administration.

Vox Mar 18, 2024

Psychedelics Are About to Become a Casualty of Oregon’s Opioid Crisis

Four years ago, the state decriminalized all drugs. Now it’s trying to course-correct — and might make a mistake in the process.

Marijuana Moment Mar 14, 2024

Utah Lawmakers Unanimously Approve Bill to Allow Psilocybin and MDMA Treatment at Hospitals

The new proposal that cleared the legislature this month provides for that regulated access at two types of health care systems in the state. Psychedelics could be administered by a privately owned, non-profit health care system with at least 15 licensed hospitals or within medical programs operated by institutions of higher education.

Denver Post Mar 13, 2024

Denver First Responders to Get Psychedelic Crisis Training

The training, developed by the MAPS, aims to “enhance the knowledge, attitudes, and skills of first responders to quickly recognize and effectively respond to emotional and behavioral crisis incidents involving psilocybin and other psychedelics.”

Pharmacy Times Mar 12, 2024

Navigating Research in Psychedelics: Investigators Face a Mosaic of Regulations, False Perceptions, and Therapeutic Potential

Psychedelic medicine investigators must contend with strict guidelines and administrative burdens, which can slow research efforts and subsequent approvals that could improve wide-spread access and economic opportunities.

Psychology Today Mar 11, 2024

Can Psychedelic-Assisted Therapy Treat Eating Disorders?

In the absence of tailored treatment options, perhaps it’s no surprise that a growing interest in Psychedelic-Assisted Therapy (PAT) for eating disorders is slowly gaining traction.

Fast Company Mar 8, 2024

The Government Finally Fast-Tracked LSD as an Anxiety Treatment

MindMed, the first publicly traded pharmaceutical company focused on psychedelics, said its drug has received a breakthrough designation from the FDA.

Marijuana Moment Mar 7, 2024

Alaska Weighs Proposal to Create Psychedelics Task Force in Anticipation of Federal Legalization

At a hearing Tuesday, members of the House Military and Veterans Affairs Committee agreed to advance the measure with individual recommendations.

Cleveland Clinic Mar 6, 2024

Cleveland Clinic Expands Psychedelic Research, Launches First Psilocybin Trial in Northeast Ohio

Cleveland Clinic is now part of a multisite trial with over 50 sites researching this drug to treat treatment-resistant depression.

New York Times Mar 5, 2024

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.